GlassScriptPhysician profile
Israel Meir Ackerman
NPI 1619402260
$3,947.38
in general payments reported to CMS, 2019-2025
13 companies · $915 in 2025
The $915 reported for 2025 was more than what 75% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $153 · 2022: $39.50 · 2023: $414 · 2024: $2,426 · 2025: $915.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,456 · Travel and Lodging: $1,298.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,456.06 |
| Travel and Lodging | $1,298.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $1,877.89 | 2023-2024 | Teneo, Envista Aspire Iol, Stellaris Elite |
| Sun Pharmaceutical Industries INC. | $661.47 | 2023-2025 | Cequa |
| Alcon Vision LLC | $366.12 | 2021-2025 | Clareon, Rocklatan, Ngenuity |
| Glaukos Corporation | $338.57 | 2021-2025 | Idosetr |
| Abbvie INC. | $263.00 | 2023-2025 | Lumigan, Alphagan P, Vuity |
| Rxsight INC | $239.73 | 2024-2025 | Rxsight Contact Lens, Light Adjustable Lens (Lal), Rxsight Injector Cartridge |
| Tarsus Pharmaceuticals, INC. | $60.65 | 2024-2025 | Xdemvy |
| Biotissue Holdings INC. | $41.69 | 2022-2023 | |
| Oyster Point Pharma, INC. | $32.55 | 2023 | Tyrvaya |
| Rayner Intraocular Lenses Limited | $19.23 | 2024 | Rayone Emv, Rayone Spheric, Rayner Cataract Set 1 |
| Thea Pharma INC. | $17.34 | 2024 | Iyuzeh |
| Novartis Pharmaceuticals Corporation | $15.91 | 2023 | |
| Johnson & Johnson Surgical Vision, INC. | $13.23 | 2023 | Tecnis Simplicity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Israel Ackerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.